Parallax Volatility Advisers, L.P. Esperion Therapeutics, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$1.2 - $1.76 $96,000 - $140,800	80,000 New	80,000 $111,000
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $174,603 - $432,696	36,300 New	36,300 $182,000
Q3 2020 Nov 13, 2020	SELL	$31.18 - $52.71 $1.25 Million - $2.11 Million	-40,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $1.2 Million - $2.05 Million	40,000 New	40,000 $2.05 Million
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $8,022 - $10,714	-200 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$36.99 - $59.11 $6.04 Million - $9.66 Million	-163,400 Reduced 99.88%	200 $9,000
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $11.8 Million - $14.9 Million	-290,000 Reduced 63.93%	163,600 $7.26 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $19.9 Million - $23.9 Million	453,600	453,600 $22.7 Million

206

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $147M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.